What does a high microalbumin(to albumin in urine)/creatinine ratio in urine, indicating microalbuminuria, of 60.8 signify?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A high microalbumin/creatinine ratio of 60.8 mg/g in urine indicates moderate albuminuria, which is an early sign of kidney damage, and requires prompt follow-up with a healthcare provider for further evaluation and management. This result suggests that the kidneys are leaking small amounts of protein (albumin) into the urine, which healthy kidneys typically don't do. Normal values are generally below 30 mg/g, while values between 30-300 mg/g indicate moderate albuminuria, and the value of 60.8 falls within this range 1.

Key Points to Consider

  • The finding of moderate albuminuria is particularly significant if the individual has diabetes or hypertension, as it may indicate early diabetic nephropathy or hypertensive kidney damage 1.
  • Additional tests to assess kidney function, such as estimated glomerular filtration rate (eGFR) and complete urinalysis, may be recommended by the healthcare provider 1.
  • Treatment typically focuses on controlling underlying conditions like diabetes and hypertension, often with medications such as ACE inhibitors or ARBs, which help protect kidney function 1.
  • Lifestyle modifications, including reducing sodium intake, maintaining healthy blood glucose levels, regular exercise, and avoiding nephrotoxic medications, are also important for managing albuminuria and slowing the progression of kidney disease.

Management and Treatment

  • ACE inhibitors should be considered for the initial treatment of hypertension, and may be used to treat microalbuminuria 1.
  • Lifestyle modifications, such as dietary changes and increased physical activity, can help control blood pressure and reduce the risk of kidney disease progression 1.
  • Regular monitoring of kidney function and urine albumin levels is necessary to assess the effectiveness of treatment and adjust the management plan as needed 1.

From the Research

Understanding Microalbumin/Creatinine Ratio

  • The microalbumin/creatinine ratio is a measure used to assess kidney function, particularly in patients with diabetes or hypertension.
  • A high microalbumin/creatinine ratio, such as 60.8, indicates the presence of microalbuminuria, which is a sign of early kidney damage or nephropathy 2, 3.

Implications of High Microalbumin/Creatinine Ratio

  • Studies have shown that a high microalbumin/creatinine ratio is associated with an increased risk of chronic kidney disease (CKD) progression in patients with type 2 diabetes mellitus 4.
  • Microalbuminuria is also a predictor of cardiovascular disease and mortality in patients with diabetes or hypertension 5, 6.

Treatment and Management

  • Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin-receptor antagonists (ARBs) have been shown to reduce microalbuminuria and slow the progression of kidney disease in patients with diabetes or hypertension 2, 5, 6.
  • Lifestyle modifications, such as blood pressure control, blood glucose management, and dietary changes, are also important in managing microalbuminuria and preventing kidney disease progression.

Monitoring and Follow-up

  • Regular monitoring of microalbumin/creatinine ratio, blood pressure, and blood glucose levels is essential in patients with diabetes or hypertension to detect early signs of kidney damage or disease progression 3, 4.
  • Early detection and treatment of microalbuminuria can help prevent or slow the progression of kidney disease and reduce the risk of cardiovascular complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effect of Lisinopril and Verapamil on Angiopoietin 2 and Endostatin in Hypertensive Diabetic Patients with Nephropathy: A Randomized Trial.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2021

Research

Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.